Identification of Inhibitors of HSF1 Functional Activity by High-Content Target-Based Screening

Abstract

Cancer cells are known to experience a high level of stress and may require constant repair for survival and proliferation. Recent studies showed that inhibition of heat shock factor 1 (HSF1), the key regulator for the stress-activated transcription of heat shock protein (HSP), can reduce the tumorigenic potential of cancer cells. Such a “nononcogene addiction” phenomenon makes HSF1 an attractive cancer drug target. Here, the authors report an image-based high-content screening (HCS) assay for HSF1 functional inhibitors. A heat shock—based methodology was used to stimulate the stress response followed by quantitative measurement of HSF1/HSP70 granules for compound-induced inhibitory effects. The authors discovered a small molecule from a compound library that inhibits HSF1 granule formation substantially in heat-shocked HeLa cells with IC₅₀ at 80 nM. Electorphoretic mobility shift of HSF1 by this compound suggested significant inhibition of HSF1 phosphorylation, accompanied by reduced expression levels of HSP70 and HSP90 after heat induction. Importantly, HeLa cells stably transfected with HSF1 shRNA were more resistant to the compound treatment under lethal temperature than cells containing HSF1, further validating an HSF1-dependent mechanism of action. The HCS assay the authors developed was robust with a Z′ factor of 0.65 in a 384-well plate format, providing a valuable method for identifying small-molecule functional inhibitors of HSF1 for potential cancer treatment. (Journal of Biomolecular Screening 2009:1165-1175)

Keywords

HSF1 HSP70 stress granule high-content screening cancer

References

Workman P. : Drugging the cancer kinome: progress and challenges in developing personalized molecular cancer therapeutics. Cold Spring Harb Symp Quant Biol 2005;70:499-515.

Sawyers CL : Making progress through molecular attacks on cancer. Cold Spring Harb Symp Quant Biol 2005;70:479-482.

Solimini NL , Luo J. , Elledge SJ : Non-oncogene addiction and the stress phenotype of cancer cells. Cell 2007;130:986-988.

Luo J. , Solimini NL , Elledge SJ : Principles of cancer therapy: oncogene and non-oncogene addiction . Cell 2009;136:823-837.

Pirkkala L. , Nykänen P. , Sistonen L. : Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J 2001;15:1118-1131.

Christians ES , Yan LJ , Benjamin IJ : Heat shock factor 1 and heat shock proteins: critical partners in protection against acute cell injury. Crit Care Med 2002;30(suppl):S43-S50.

Dai C. , Whitesell L. , Rogers AB , Lindquist S. : Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis . Cell 2007;130:1005-1018.

Drysdale MJ , Brough PA , Massey A. , Jensen MR , Schoepfer J. : Targeting Hsp90 for the treatment of cancer . Curr Opin Drug Discov Devel 2006;9:483-495.

Solit DB , Rosen N. : Hsp90: a novel target for cancer therapy. Curr Top Med Chem 2006;6:1205-1214.

10.

Workman P. , Burrows F. , Neckers L. , Rosen N. : Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress. Ann N Y Acad Sci 2007;1113:202-216.

11.

Bagatell R. , Paine-Murrieta GD , Taylor CW , Pulcini EJ , Akinaga S. , Benjamin IJ , Whitesell L. : Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents. Clin Cancer Res 2000;6:3312-3318.

12.

Gabai VL , Budagova KR , Sherman MY : Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents. Oncogene 2005;24:3328-3338.

13.

Guo F. , Rocha K. , Bali P. , Pranpat M. , Fiskus W. , Boyapalle S. , et al: Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylaminodemethoxy geldanamycin. Cancer Res 2005;65:10536-10544.

14.

Cotto J. , Fox S. , Morimoto R. : HSF1 granules: a novel stress-induced nuclear compartment of human cells. J Cell Sci 1997;110(pt 23): 2925-2934.

15.

Nonaka T. , Akimoto T. , Mitsuhashi N. , Tamaki Y. , Nakano T. : Changes in the number of HSF1 positive granules in the nucleus reflects heat shock semiquantitatively. Cancer Lett 2003 ;202:89-100.

16.

Zeng XC , Bhasin S. , Wu X. , Lee JG , Maffi S. , Nichols CJ , et al: Hsp70 dynamics in vivo: effect of heat shock and protein aggregation . J Cell Sci 2004;117(pt 21):4991-5000.

17.

Alastalo TP , Hellesuo M. , Sandqvist A. , Hietakangas V. , Kallio M. , Sistonen L. : Formation of nuclear stress granules involves HSF2 and coincides with the nucleolar localization of Hsp70. J Cell Sci 2003;116(pt 17): 3557-3570.

18.

Au Q. , Kanchanastit P. , Barber JR , Ng SC , Zhang B. : High-content image-based screening for small-molecule chaperone amplifiers in heat shock. J Biomol Screen 2008;13:953-959.

19.

Guettouche T. , Boellmann F. , Lane WS , Voellmy R. : Analysis of phosphorylation of human heat shock factor 1 in cells experiencing a stress . BMC Biochem 2005;11(6):4.

20.

Zaarur N. , Gabai VL , Porco JA Jr , Calderwood S. , Sherman MY : Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors. Cancer Res 2006;66:1783-1791.

21.

Zhang B. , Gu X. , Uppalapati U. , Ashwell MA , Leggett DS , Li CJ : High-content fluorescent-based assay for screening activators of DNA damage checkpoint pathways. J Biomol Screen. 2008 ;13: 538-543.

22.

Nagai N. , Nakai A. , Nagata K. : Quercetin suppresses heat shock response by down regulation of HSF1 . Biochem Biophys Res Commun 1995;208: 1099-1105.

23.

Yokota S. , Kitahara M. , Nagata K. : Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells. Cancer Res 2000;60:2942-2948.

24.

Westerheide SD , Kawahara TL , Orton K. , Morimoto RI : Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J Biol Chem 2006;281:9616-9622.